Tahir Amin, of the Initiative for Medicines, Access & Knowledge, challenges the practice of extending patents, which he believes is restricting patients’ access to the treatments they need.

Medicines for Europe proposes that additional policies are needed on the demand side. Current pricing policies are aimed at increasing price competition among off-patent medicines in order to ...